Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS)

Clinical trial NCT04174716 · COMPLETED

Trial details

NCT number: NCT04174716
Sponsor: Idience Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumors Homologous Recombination Repair Gene Mutation Homologous Recombination Deficiency

Start date: 2019-11-06
Primary completion: 2023-03-31
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.